Latest news with #NAD
The Herald Scotland
4 days ago
- Politics
- The Herald Scotland
Deaf Americans sue Trump over loss of ASL translators at briefings
The lawsuit says Trump stopped using sign language interpreters upon taking office a second time, violating the 2020 ruling by Judge James Boasberg, who at the time said providing closed captioning or written transcripts is insufficient. Boasberg is the chief judge for the U.S. District Court for the District of Columbia, and has been repeatedly criticized by Trump over unrelated immigration rulings. "Federal law unequivocally prohibits discrimination against individuals with disabilities and requires them to have meaningful access to the federal government's programs and services," the lawsuit alleges. "Failing to provide ASL interpreters deprives deaf people of meaningful access to the White House's press briefings." The lawsuit includes two Deaf people - Derrick Ford and Matthew Bonn - as plaintiffs, and notes that hundreds of thousands of deaf Americans speak only ASL, and may not communicate at all in English. Trump in March declared English to be the official language of the United States, and rescinded a 2000 executive order that encouraged the executive branch to make services available to people of limited English proficiency, including ASL speakers. The NAD asked the White House to reinstate ASL translation but received no response, the group said in its lawsuit. Members of the Deaf community have long worried about lack of access to ASL interpreters, especially during times of crisis. The 2020 lawsuit from the NAD specifically cited the ongoing pandemic as a reason for having real-time translations instead of providing closed captioning or transcripts. ASL translators have also become an increasingly common sight at concerts, with Taylor Swift, among others, using them to bring lyrics to life for deaf people.
USA Today
4 days ago
- Politics
- USA Today
Deaf Americans sue Trump over lack of sign language interpreters for White House events
Deaf Americans sue Trump over lack of sign language interpreters for White House events A 2020 court ruling mandated the White House provide real-time translations via American Sign Language. President Trump halted their use in January. Show Caption Hide Caption What is 'TACO trade,' a new phrase angering President Trump? 'TACO trade' is a jab at President Donald Trump's propensity to impose or threaten tariffs and later back off. WASHINGTON - A group of Deaf Americans who previously forced the White House to provide American Sign Language interpreters during press briefings is asking a federal judge to again intervene after President Donald Trump halted their use in January. In a lawsuit filed May 28, the National Association of the Deaf argued that the Trump White House's removal of ASL interpreters at press conferences and briefings violates federal law. The same group previously forced the White House to provide interpreters for COVID-19 briefings during Trump's first presidency, and former President Joe Biden expanded their use when he took office. The lawsuit says Trump stopped using sign language interpreters upon taking office a second time, violating the 2020 ruling by Judge James Boasberg, who at the time said providing closed captioning or written transcripts is insufficient. Boasberg is the chief judge for the U.S. District Court for the District of Columbia, and has been repeatedly criticized by Trump over unrelated immigration rulings. "Federal law unequivocally prohibits discrimination against individuals with disabilities and requires them to have meaningful access to the federal government's programs and services," the lawsuit alleges. "Failing to provide ASL interpreters deprives deaf people of meaningful access to the White House's press briefings." The lawsuit includes two Deaf people − Derrick Ford and Matthew Bonn − as plaintiffs, and notes that hundreds of thousands of deaf Americans speak only ASL, and may not communicate at all in English. Trump in March declared English to be the official language of the United States, and rescinded a 2000 executive order that encouraged the executive branch to make services available to people of limited English proficiency, including ASL speakers. The NAD asked the White House to reinstate ASL translation but received no response, the group said in its lawsuit. Members of the Deaf community have long worried about lack of access to ASL interpreters, especially during times of crisis. The 2020 lawsuit from the NAD specifically cited the ongoing pandemic as a reason for having real-time translations instead of providing closed captioning or transcripts. ASL translators have also become an increasingly common sight at concerts, with Taylor Swift, among others, using them to bring lyrics to life for deaf people.
Newsweek
4 days ago
- Politics
- Newsweek
Deaf Association Sues Trump for Lack of ASL Interpreters at Press Briefings
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The National Association of the Deaf (NAD) sued President Donald Trump and several co-defendants for failing to provide qualified ASL interpreters at public press briefings and similar events. The lawsuit, filed on Wednesday, alleges that the White House stopped using ASL interpreters in January, "denying hundreds of thousands of deaf Americans meaningful access to the White House's real-time communications on various issues of national and international import." The Executive Office of the President, The White House Office, Office of the Vice President, White House Chief of Staff Susan Wiles and Press Secretary Karoline Leavitt were also named as defendants in the suit. Newsweek reached out to attorneys for the plaintiffs and the White House for comment. Why It Matters ASL is the primary and preferred language of many deaf individuals. The language has a unique vocabulary, grammar and syntax. "Many deaf individuals cannot read or understand written English. Consequently, English closed captions are not an adequate substitute for ASL interpretation," attorneys for the plaintiffs said in the complaint. The Trump administration faced a similar legal challenge during the first term of his presidency. The NAD filed a lawsuit against Trump and several others in 2020 for failure to provide in-frame ASL interpretation during COVID-19 briefings. President Donald Trump speaking during a swearing in ceremony for interim U.S. Attorney General for the District of Columbia Jeanine Pirro, Wednesday, May 28, 2025, in the Oval Office of the Washington. President Donald Trump speaking during a swearing in ceremony for interim U.S. Attorney General for the District of Columbia Jeanine Pirro, Wednesday, May 28, 2025, in the Oval Office of the Washington. AP Photo/Evan Vucci Under a judge's injunction, the administration was required to provide in-frame interpretation or a simultaneous stream with an interpreter from a remote location in a picture-in-picture format. The case was dismissed in 2021 after then-President Joe Biden took office. The Biden administration laid out its commitment to providing ASL interpretation in a memo entitled "Communication Services for People Who Are Deaf or Hard of Hearing at Presidential Briefings." The policy stated that a qualified interpreter would be provided at briefings held by the President, Vice President, First Lady, Second Gentleman or White House Press Secretary, in addition to COVID-19 briefings and any other briefings approved by designated White House officials. The policy remained in effect throughout Biden's presidency. What To Know The NAD and two of its members, 36-year-old Indiana resident Derrick Ford and 48-year-old Maryland resident Matthew Bonn, allege that the failure to provide ASL interpreters is a violation of federal law prohibiting discrimination against individuals with disabilities and requiring access to the federal government's programs and services. Attorneys for the plaintiffs said both Ford and Bonn were unable to understand much of what was being said at White House press briefings, depriving them of information on executive orders, DEI, Social Security, Medicare, Medicaid, the economy and other issues impacting Americans. "It is apparent that the White House is not complying with the Policy announced and followed by the prior administration," attorneys for the plaintiffs wrote in the complaint. The NAD sent a letter to Wiles urging the White House to reinstate ASL interpreters in January, but the association has not received a response, according to the suit. The plaintiffs are asking the court to provide injunctive relief requiring the defendants to provide qualified ASL interpreters at press briefings, press conferences and related events held by the president, vice president, first lady, second lady or White House press secretary. The plaintiffs are also asking that the interpreters be visible in frame, both in television broadcasts and videos streamed or uploaded to the White House's website or social media pages. What People Are Saying Attorneys for the plaintiffs, in a complaint filed Wednesday: "Such fluent and accurate interpretations are critical for deaf Americans, especially in times of great and frequent change." Dr. Bobbie Beth Scoggins, Interim Chief Executive Officer of the NAD, in a statement: "Deaf and hard of hearing Americans have the right to the same access to White House information as everyone else. Denying them ASL interpreters is a direct violation of that right, and the NAD will continue to fight for their full inclusion in the democratic process." What Happens Next Summons were issued for the defendants, who will have 60 days to respond after being successfully served. Do you have a story that Newsweek should be covering? Do you have any questions about this story? Contact LiveNews@
Medical News Today
7 days ago
- Health
- Medical News Today
NAD aging: Benefits, risks, and more
Medically reviewed by Shilpa Amin, M.D., CAQ, FAAFP, Family Medicine , Women's Health , Geriatrics , Integrative Medicine , Clinical Research , Jurisprudence , — Written by Louise Morales-Brown on May 21, 2025 Benefits for older adults Possible risks Healthy aging tips Summary Nicotinamide adenine dinucleotide (NAD) is a coenzyme that plays a key role in many biological processes. More research is necessary, but some studies suggest that NAD may help reduce the risk of aging-related diseases. NAD is an essential enzyme that has a role in many important cell functions, such as energy metabolism, DNA repair, and cellular health. NAD levels naturally decline with age and may relate to various signs of aging, such as lower energy, impaired cellular repair, and higher risk of age-related diseases. As such, some health experts believe that increasing NAD may help promote longevity and slow the aging process. However, there is currently no conclusive evidence that NAD supplementation can slow aging, and more research is necessary to understand its possible benefits. Stefania Pelfini, LaIn 1937, a biochemist called Conrad Elvehjem first established a link between low levels of NAD and aging. Since, researchers found that NAD levels decrease with age, as well as exposure to certain stressors and disease. As such, some evidence suggests that lower NAD levels may result in aging and age-related disease. Due to its role in the aging process, growing research indicates that boosting NAD may provide health benefits and delay signs of aging. Healthy lifestyle choices, such as regular exercise, sufficient sleep, and a balanced dietary plan may help to extend life expectancy, possibly due to increasing NAD levels. Therefore, it may be possible to get similar benefit by increasing NAD levels through taking NAD precursors or boosters. At present, most research into NAD precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), is in the form of animal studies. The results of these studies suggest that NAD precursors could help to extend health span and reduce premature aging in animal models. A 2023 review indicates that NAD precursors are generally safe and may have the potential to support graceful aging in humans. However, the review also emphasizes that further research is necessary in humans, particularly to determine the possible effects and safety of these supplements. Although NAD supplements are showing promise as agents that support graceful aging, there are still some concerns about their safety profile and possible long-term effects. For example, a 2022 review highlights potential concerns about adverse effects on several organs, such as the kidney, liver, pancreas, and stomach. However, the review also notes that other research suggests that NAD could provide several benefits for these organs. As such, more research is still necessary to establish the safety profile, appropriate dosages, and long-term effects of these supplements. Researchers must also determine the most effective way to administer these products, which could include dietary supplements, injections, or topical solutions. Instead, it recognizes NMN as a drug due to its potential ability to support graceful aging. Therefore, it must receive FDA approval for both safety and effectiveness before manufacturers can market it as a product that supports graceful aging. Therefore, it is advisable for a person to consult their doctor before taking any NAD supplements. Many factors can influence aging. Some of these factors, such as genetics, are not modifiable. However, others are modifiable, meaning that people can make certain lifestyle choices to help prevent some health problems and promote healthy aging. Some tips for healthy aging can include : following a healthy, balanced dietary plan regular physical activity maintaining a healthy weight to help prevent health problems getting sufficient sleep keeping the mind stimulated and active, through memory games, learning new skills, reading, and playing games maintaining mental health, through socializing, relaxation techniques, and mindfulness regularly participating in enjoyable activities, such as hobbies, social, and leisure activities playing an active role in healthcare, such as attending regular checkups, vaccines, and health screenings avoiding or reducing activities that can be harmful to health, such as smoking or consuming alcohol taking steps to prevent injury, including safe driving and reducing the risk of falls Nicotinamide adenine dinucleotide (NAD) is an important coenzyme that likely plays a role in the aging process. As people age, their levels of NAD naturally decline, which may increase their risk of age-related diseases. Growing research in animal models suggests that boosting NAD levels may help to improve life span and prevent or delay certain health conditions. However, more research in humans is necessary to establish whether NAD supplements are safe and if they can provide health benefits. Supplements Seniors / Aging Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy. Bhasin S, et al. (2023). Nicotinamide adenine dinucleotide in aging biology: Potential applications and many unknowns. Braidy N, et al. (2018). Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: Rationale, biochemistry, pharmacokinetics, and outcomes. Conlon NJ. (2021). The role of NAD+ in regenerative medicine. Covarrubias AJ, et al. (2021). NAD + metabolism and its roles in cellular processes during ageing. Healthy aging. (2024). Healthy aging at any age. (2024). Henderson JD, et al. (2024). The use of a systems approach to increase NAD + in human participants. Igbal T, et al. (2024). The therapeutic perspective of NAD + precursors in age-related diseases. Lam C, et al. (2023). Food, drug, and cosmetic act. McReynolds MR, et al. (2021). Age-related NAD + decline. Nadeeshani H, et al. (2022). Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns. Poljsak B, et al. (2020). Healthy lifestyle recommendations: Do the beneficial effects originate from NAD + amount at the cellular level? Song Q, et al. (2023). The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: An update. Wrinkle treatments and other anti-aging products. (2022).
Yahoo
7 days ago
- Business
- Yahoo
Following National Advertising Division Inquiry, Ezra AI Voluntarily Discontinues Claims for Full Body MRI Medical Service
In a BBB National Programs National Advertising Division challenge brought by Prenuvo, Inc., Ezra AI Inc. voluntarily discontinued comparative advertising claims for its Medical Service: Full Body MRI. New York, NY, May 27, 2025 (GLOBE NEWSWIRE) -- In a BBB National Programs National Advertising Division challenge brought by Prenuvo, Inc., Ezra AI Inc. voluntarily discontinued comparative advertising claims for its Medical Service: Full Body MRI. Prenuvo and Ezra are competitors in whole-body medical MRI scans. Prenuvo challenged claims on Ezra's website comparing the services offered by Ezra to those offered by Prenuvo, arguing that Ezra's advertising misleadingly conveyed the unsupported message that Ezra's services are superior to those offered by Prenuvo. During the challenge, Ezra voluntarily permanently discontinued all of the challenged claims. The voluntarily discontinued claims will be treated, for compliance purposes, as though NAD recommended they be discontinued. In its advertiser statement, Ezra stated it 'agrees to comply with NAD's recommendations, which were voluntarily undertaken by Ezra.' All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes. About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business. CONTACT: Name: Jennie Rosenberg Email: jrosenberg@ Job Title: Media RelationsError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
